Anaptysbio (ANAB) Change in Acquisitions & Divestments (2017 - 2026)

Anaptysbio (ANAB) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $35.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 74.53% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $322.1 million (down 33.71% YoY) and the FY2025 annual result came in at $424.5 million, down 10.84% from the prior year.
• Change in Acquisitions & Divestments slipped to $35.0 million in Q1 2026, from $73.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $149.2 million in Q4 2022 to a low of $9.6 million in Q1 2022.
• A 5-year average of $105.5 million and a median of $110.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 84.8% — and 2023, when it surged 1294.24%.
• Tracing ANAB's Change in Acquisitions & Divestments over 5 years: stood at $149.2 million in 2022, then decreased by 22.44% to $115.8 million in 2023, then dropped by 20.75% to $91.7 million in 2024, then fell by 19.89% to $73.5 million in 2025, then plunged by 52.38% to $35.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $35.0 million (Q1 2026), $73.5 million (Q4 2025), and $123.0 million (Q3 2025), per Business Quant data.